Biotech investing is a high-stakes game that may not suit the faint-hearted due to its inherent volatility. However, this sector can offer astronomical returns when investors time their entries correctly. The following biotech stocks we profiled on our site reached 52-week highs yesterday.
*Last Closing Price refers to the stock's closing price on Sep.19, 2024.
Ticker
Published Date
Published Price
Maximum Price Since Publication
*Last Closing Price
Maximum Gain %
Edgewise Therapeutics, Inc. (EWTX)
Oct.16, 2023
$6.71
$30.00
$29.50
347%
Travere Therapeutics Inc. (TVTX)
Aug.14, 2024
$8.91
$15.23
$15.06
71%
Catalyst Pharmaceuticals Inc. (CPRX)
Feb.13, 2024
$13.32
$21.36
$21.35
60%
MannKind Corp. (MNKD)
Apr.8, 2024
$4.47
$6.92
$6.70
55%
Rockwell Medical Inc. (RMTI)
Sep.4, 2024
$3.21
$4.45
$4.14
38%
Rhythm Pharmaceuticals Inc. (RYTM)
Dec.1, 2023
$33.66
$55.64
$54.55
65%
Eton Pharmaceuticals Inc. (ETON)
Sep.8, 2023
$4.51
$6.02
$5.90
33%
Vaxcyte Inc. (PCVX)
Apr.30, 2024
$60.61
$121.06
$117.12
99%
RadNet Inc. (RDNT)
Mar.1, 2023
$23.47
$70.37
$69.64
199%
Merit Medical Systems Inc. (MMSI)
Oct.27, 2022
$62.71
$101.26
$100.23
61%
ADMA Biologics Inc. (ADMA)
Feb.15, 2024
$5.36
$19.92
$19.74
271%
Related Reading
ACLX, HROW Deliver Triple-Digit Returns - Did You Cash In?
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.